Accession Number:

AD1038259

Title:

Discovering drugs for the treatment of Ebola virus

Corporate Author:

USAMRIID Ft Detrick United States

Report Date:

2017-08-04

Abstract:

Drug development for Ebola virus EBOV has been in progress for several decades, primarily fueled by concerns about the potential use of the Category A agent as a potential bioweapon. However, the unprecedented magnitude and scale of the 2014-2016 outbreak in West Africa, combined with the potential spread to other corners of the world, led to a renewed focus on medical countermeasures for Ebola virus disease EVD.

Descriptive Note:

Journal Article

Supplementary Note:

Current Treatment Options in Infectious Diseases , 01 Jan 0001, 01 Jan 0001,

Pages:

0019

Distribution Statement:

Approved For Public Release;

File Size:

0.85MB